Table 2.

Participant characteristics at each clinic site at baseline and follow-up

CLINIC SITE	N	SMOKING PREVALENCE N (%)	FEMALE SEX, %	*PATIENTS AGED > 65 Y,^ %**	CDM PATIENTS, %	SMOKING STATUS UNKNOWN,^† %	READINESS TO QUIT ASSESSED,^‡ %
Baseline
• A	325	75 (23)	63	34	28	22	48
• C	496	65 (13)	46	20	36	0	45
• D	247	9 (4)	74	18	17	58	0
• E	296	61 (21)	53	27	29	10	28
• F	201	122(61)	32	6	2	25	0
• Total	1565	332(21)	54	23	27	27	25
Follow-up
• A	301	46 (15)	59	45	23	9	85
• C	301	56 (19)	51	28	26	6	34
• D	220	5 (2)	48	34	42	78	100
• E	300	62 (21)	59	32	25	6	19
• F	187	119(64)	25	7	9	20	38
• Total	1309	288(22)	50	31	25	21	42

CDM—chronic disease management.
↵* A minor change in the age groupings occurred at follow-up when a pull-down system was used to aid data entry, so follow-up data are for patients aged older than 60 y.
↵† Refers to all patients.
↵‡ Refers to smoking patients.